U.S. Patent 7657297 was awarded to DexCom, Inc. on 2010-02-02 and describes a “Implantable analyte sensor.” This patent has been cited 383 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

An implantable analyte sensor including a sensing region for measuring the analyte and a non-sensing region for immobilizing the sensor body in the host. The sensor is implanted in a precisely dimensioned pocket to stabilize the analyte sensor in vivo and enable measurement of the concentration of the analyte in the host before and after formation of a foreign body capsule around the sensor. The sensor further provides a transmitter for RF transmission through the sensor body, electronic circuitry, and a power source optimized for long-term use in the miniaturized sensor body. Link: U.S. Patent 7657297

This patent was originally filed on 2004-05-03 which gives it a processing time of 2101 days, compared to an average processing time of 1696 in the field. DexCom, Inc. has 423 total patents. The first named inventor is Mark C. Shults of Madison, NC. The primary examiner was Charles A Marmor, II.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/